| Application no. and date | 20900848.1 (espacenet) (Federated) (European Patent Register), 20201215 | | Patent/reg. no. and date | DK/EP 4076398, 20260218 | | Publication date | 20221026 | | Priority no. and date | US 201962948735 P, 20191216, US 202062967920 P, 20200130, US 202062988720 P, 20200312, US 202063033773 P, 20200602, US 202063064671 P, 20200812 | | EP pub. no. and date |
EP 4076398 20221026 | | Effective date | | | Applicant/owner | Tenax Therapeutics, Inc., One Copley Parkway, Suite 490
Morrisville, NC 27560, US | | Applicant ref. no. | | | Inventor | RANDALL, Douglas, C/o Tenax Therapeutics, Inc. 1 Copley Parkway,
Suite 490
Morrisville, NC 27560, US,
HAY, Douglas, 497 Geigel Hill Road
Ottsville, PA 18942, US,
RICH, Stuart,
Skokie, IL 60076, US | | Representative | | | Opponent | | | IPC Class | A61K 31/216 (2006.01) , A61K 31/41 (2006.01) , A61K 31/495 (2006.01) , A61K 31/50 (2006.01) , A61K 9/00 (2006.01) , A61K 9/08 (2006.01) , A61P 9/04 (2006.01) , A61P 9/12 (2006.01) | | Title | LEVOSIMENDAN FOR TREATING PULMONARY HYPERTENSION WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (PH-HF-pEF) | | Int. application no. | US2020065166 | | Int. publication no. | WO2021126884 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
